UPDATED May 27, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
MYO | US$3.83 | 2.1% | 616.8% | US$110.4m | US$6.60 | PS5.6x | E66.0% | n/a | ||
ESTA | US$53.54 | -0.9% | -17.4% | US$1.5b | US$63.00 | PS9.5x | E68.2% | n/a | ||
HSCS | US$6.20 | 5.4% | -94.2% | US$4.1m | US$67.50 | PS218.5x | E66.8% | n/a | ||
NXGL | US$2.35 | 1.7% | 2.6% | US$14.6m | US$6.00 | PS3.1x | E67.5% | n/a | ||
ECOR | US$6.84 | -2.1% | 35.8% | US$41.1m | US$23.16 | PS2.2x | E69.5% | n/a | ||
HIMS | US$16.88 | -9.2% | 86.1% | US$3.6b | US$17.17 | PS3.8x | E39.9% | n/a | ||
GMED | US$65.82 | -0.7% | 24.4% | US$8.9b | US$70.42 | PE133.4x | E40.9% | n/a | ||
SLP | US$49.83 | -0.4% | 10.7% | US$995.8m | US$53.67 | PE94.7x | E29.5% | 0.5% | ||
ASTH | US$39.97 | 2.3% | 27.8% | US$2.0b | US$54.20 | PE31.3x | E18.6% | n/a | ||
AIRS | US$3.51 | -18.6% | -53.4% | US$202.1m | US$5.00 | PE129.2x | E53.8% | n/a | ||
VMD | US$7.06 | -0.6% | -24.6% | US$274.1m | US$12.75 | PE26.5x | E32.2% | n/a | ||
SRTS | US$6.10 | -2.6% | 127.6% | US$100.0m | US$9.00 | PE21.5x | E30.9% | n/a |